Refinement of the commonly deleted segment in myeloid leukemias with a del(20q)

Genes Chromosomes and Cancer

Volumn 21, Issue 2, 1998, Pages 75-81

  Wang, Pauline W ^a   Iannantuoni, Kiera ^a   Davis, Elizabeth M ^a   Espinosa III, Rafael ^a   Stoffel, Markus ^b   Le Beau, Michelle M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ARTICLE; CHROMOSOME 20Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME MAP; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; YEAST ARTIFICIAL CHROMOSOME;

ALLELES; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 20; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MICROSATELLITE REPEATS;

EID: 0031891532     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199802)21:2<75::AID-GCC1>3.0.CO;2-4     Document Type: Article

References (24)

1. Aatola M, Armstrong E, Teerenhovi L, Borgström GH (1992) Clinical significance of the del(20q) chromosome in hematologic disorders. Cancer Genet Cytogenet 62:75-80.
2. Asimakopoulos FA, White NJ, Nacheva E, Green AR (1994) Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 84:3086-3094.
3. Asimakopoulos FA, Gilbert JGR, Aldred MA, Pearson TC, Green AR (1996) Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera. Blood 88:2690-2698.
4. Burgess WH, Dionne CA, Kaplow JM, Mudd R, Friesel R, Zilberstein A, Schlessinger J, Jaye M (1990) Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase. Mol Cell Biol 10:4770-4777.
5. Chartier FL, Bossu JP, Laudet V, Fruchart JC, Laine B (1994) Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liver. Gene 147:269-272.
6. Chumakov IM, Rigault P, Le Gall I, Bellanné-Chantelot C, Billault A, Guillou S, Soularue P, Guasconi G, Poullier E, Gros I, Belova M, Sambucy J-L, Susini L, Gervy P, Gilbert F, Beaufils S, Bui H, Massart C, De Tand M-F, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cohen-Akenine A, Barillot E, Bertrand S, Codani J-J, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Tubacher E, Dib C, Fauré S, Fizames C, Gyapay G, Millasseau P, NGuyen S, Muselet D, Vignal A, Morissette J, Menninger J, Lieman J, Desai T, Banks A, Bray-Ward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbach J, Le Paslier D, Cohen D (1995) A YAC contig map of the human genome. Nature 377:175-297.
7. D'Arpa P, Machlin PS, Ratrie H III, Rothfield NF, Cleveland DW, Earnshaw WC (1988) cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci USA 85: 2543-2547.
8. Davis MP, Dewald GW, Pierre RV, Hoagland HC (1984) Hematologic manifestations associated with deletions of the long arm of chromosome 20. Cancer Genet Cytogenet 12:63-71.
9. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Lathrop M, Weissenbach J (1994) The 1993-94 Généthon human genetic linkage map. Nature Genet 7:246-339.
10. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, Hu X, Colbert AME, Rosenberg C, Reeve-Daiy MP, Rozen S, Hui L, Wu X, Vestergaard C, Wilson KM, Bae JS, Maitra S, Ganiatsas S, Evans CA, DeAngelis MM, Ingalls KA, Nahf RW, Horton Jr LT, Anderson MO, Collymore AJ, Ye W, Kouyoumjian V, Zemsteva IS, Tam J, Devine R, Courtney DF, Renaud MT, Nguyen H, O'Connor TJ, Fizames C, Fauré S, Gyapay G, Dib C, Morissette J, Orlin JB, Birren BW, Goodman N, Weissenbach J, Hawkins TL, Foote S, Page DC, Lander ES (1995) An STS-based map of the human genome. Science 270:1945-1954.
11. ISCN (1995): An International System for Human Cytogenetic Nomenclature. Mitelman F (ed). Basel: S. Karger, 1995.
12. Le Beau MM, Westbrook CA, Diaz MO, Rowley JD (1985) c-src is consistently conserved in the chromosomal deletion (20q) observed in myeloid disorders. Proc Natl Acad Sci USA 82:6692-6696.
13. Le Beau MM, Espinosa R III, Davis EM, Eisenbart JD, Larson RA, Green ED (1996) Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88:1930-1935.
14. Merino A, Madden KR, Lane WS, Champoux JJ, Reinberg D (1993) DNA topoisomerase 1 is involved in both repression and activation of transcription. Nature 365:227-232.
15. Mitelman F (1994) Catalog of chromosome aberrations in cancer. 5th Ed. New York: Wiley-Liss, New York.
16. Morris CM, Honeybone LM, Hollings PE, Fitzgerald PH (1989) Localization of the SRC oncogene to chromosome band 20q11.2 and loss of this gene with deletion (20q) in two leukemic patients. Blood 74:1768-1773.
17. Nacheva E, Holloway T, Carter N, Grace C, White N, Green AR (1995) Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes. Cancer Genet Cytogenet 80:87-94.
18. Reeves BR, Lobb DS, Lawler SD (1972) Identity ot the abnormal F-group chromosome associated with polycythemia vera. Humangenetik 14:159-161.
19. Rhee SG, Suh PG, Ryu SH, Lee SY (1989) Studies of inositol phospholipid- specific phospholipase C. Science 244:546-550.
20. Roulston R, Espinosa R III, Stoffel M, Bell GI, Le Beau MM (1993) Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood 82:3424-3429.
21. Stoffel M, Le Beau MM, Espinosa R III, Bohlander SF, Le Paslier D, Cohen D, Xiang K-S, Cox NJ, Fajans SS, Bell GI (1996) A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY 1, and a myeloid leukemia related gene. Proc Natl Acad Sci USA 93:3937-3941.
22. Testa JR, Kinnealey A, Rowley JD, Golde DW, Potter D (1978) Deletion of the long arm of chromosome 20 [del(20)(q11] in myeloid disorders. Blood 52:868-877.
23. Wang PW, Iannentuoni K, Davis EM, Espinosa R III, Stoffel M, Le Beau MM (1996) Refinement of the commonly deleted segment of chromosome 20 in myeloid leukemias with a del(20q). J Amer Soc Hem 88, Supp 1:6A.
24. Wiginton DA, Kaplan DJ, States JC, Akeson AL, Perme CM, Bilyk IJ, Vaughn AJ, Lattier DL, Hutton JJ (1986) Complete sequence and structure of the gene for human adenosine deaminase. Biochemistry 25:8243-8244.